Principal, Commercial Planning and Portfolio Optimisation
Mr. Rutkowski’s career has focused on US healthcare commercial planning and strategic marketing across a wide range of therapeutic areas. In particular, Mr. Rutkowski excels at developing patient and physician market assessments, buying processes as well as general launch strategies. He skillfully employs statistical techniques to develop patient and physician segmentations that combine attitudes and behaviors to drive impact and inform decision making across commercial planning, marketing, and sales.
Additionally, Mr. Rutkowski has robust knowledge of medication utilization model development and is able to use a number of statistical approaches to analyze market data.
Clinical Trial Disruptions: Can Small-Cap Biopharma Companies Weather the Impact of COVID-19?
29 April 2020
Tumor-Agnostic Therapies: The Complex Path to Commercial Viability
24 March 2020
Why I became a Healthcare Consultant
15 April 2019
Applying Technology in Pharma (ATP): Assessment of Investment Trends in Digital Health
6 March 2019
Vermont’s Drug Importation: Rubber, Meet Road
21 February 2019